In Vitro Interaction between Cefixime and Amoxicillin-Clavulanate against Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli Causing Urinary Tract Infection | Zendy

Édouard Bingen | Zendy; Philippe Bidet | Zendy; André Birgy | Zendy; Elsa Sobral | Zendy; Patricia Mariani | Zendy; Robert Cohen | Zendy

Open Access

In Vitro Interaction between Cefixime and Amoxicillin-Clavulanate against Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli Causing Urinary Tract Infection

Author(s) -

Édouard Bingen,

Philippe Bidet,

André Birgy,

Elsa Sobral,

Patricia Mariani,

Robert Cohen

Publication year - 2012

Publication title -

journal of clinical microbiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.349

H-Index - 255

eISSN - 1070-633X

pISSN - 0095-1137

DOI - 10.1128/jcm.00526-12

Subject(s) - cefixime , beta lactamase , microbiology and biotechnology , escherichia coli , urinary system , amoxicillin , enterobacteriaceae , in vitro , biology , cephalosporin , antibiotics , genetics , gene , endocrinology

We read with interest the article by Campbell et al. ([4][1]) suggesting that the combination of clavulanate and oral expanded-spectrum cephalosporins (OESCs) could be an interesting therapeutic option for urinary tract infection (UTI) due to Escherichia coli producing extended-spectrum beta-

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research